Setting new benchmarks in cancer treatment research, Cytiva’s Via Extractor tissue disaggregator is being used to create dissociated tumor cell suspensions with high viability and yield. The collaboration focuses on… Read More
New post-hoc analysis demonstrated efficacy of RINVOQ® (upadacitinib) in moderate-to-severe atopic dermatitis patients with varying degrees of severity in head and neck involvement, with results in skin clearance, itch resolution and impact on quality of life… Read More
The UK’s national charity for working parents and carers, Working Families, has announced that Gowling WLG has been awarded a place on its prestigious and competitive list of the top… Read More
VANCOUVER, BC – The future is bright, and it’s filled with girls and science, technology, engineering, arts & design, and math (STEAM)! Science World’s 7th Annual Girls and STEAM Summit, presented… Read More
First regulatory authorization of a CRISPR-based gene-editing therapy in Canada TORONTO, ON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced Health Canada has granted Marketing Authorization for PrCASGEVY® (exagamglogene autotemcel), an autologous genome… Read More
